IL150988A0 - Endoparasiticidal agents - Google Patents

Endoparasiticidal agents

Info

Publication number
IL150988A0
IL150988A0 IL15098801A IL15098801A IL150988A0 IL 150988 A0 IL150988 A0 IL 150988A0 IL 15098801 A IL15098801 A IL 15098801A IL 15098801 A IL15098801 A IL 15098801A IL 150988 A0 IL150988 A0 IL 150988A0
Authority
IL
Israel
Prior art keywords
endoparasiticidal agents
endoparasiticidal
agents
Prior art date
Application number
IL15098801A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL150988A0 publication Critical patent/IL150988A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL15098801A 2000-02-22 2001-02-09 Endoparasiticidal agents IL150988A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel
PCT/EP2001/001392 WO2001062268A1 (de) 2000-02-22 2001-02-09 Endoparasitizide mittel

Publications (1)

Publication Number Publication Date
IL150988A0 true IL150988A0 (en) 2003-02-12

Family

ID=7631886

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15098801A IL150988A0 (en) 2000-02-22 2001-02-09 Endoparasiticidal agents
IL150988A IL150988A (en) 2000-02-22 2002-07-30 Preparations against internal parasites

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150988A IL150988A (en) 2000-02-22 2002-07-30 Preparations against internal parasites

Country Status (25)

Country Link
US (1) US20030125244A1 (enExample)
EP (1) EP1259250B1 (enExample)
JP (2) JP5596249B2 (enExample)
KR (1) KR100755414B1 (enExample)
CN (1) CN1309415C (enExample)
AR (2) AR028218A1 (enExample)
AT (1) ATE343394T1 (enExample)
AU (2) AU4060501A (enExample)
BR (1) BR0108562B1 (enExample)
CA (1) CA2400610C (enExample)
CZ (1) CZ300242B6 (enExample)
DE (2) DE10008128A1 (enExample)
DK (1) DK1259250T3 (enExample)
ES (1) ES2274871T3 (enExample)
HK (1) HK1054326B (enExample)
HU (1) HUP0204554A3 (enExample)
IL (2) IL150988A0 (enExample)
MX (1) MXPA02008210A (enExample)
NO (1) NO328949B1 (enExample)
NZ (1) NZ520856A (enExample)
PL (1) PL203999B1 (enExample)
PT (1) PT1259250E (enExample)
RU (1) RU2292905C2 (enExample)
WO (1) WO2001062268A1 (enExample)
ZA (1) ZA200205982B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
ES2318053T3 (es) * 2002-11-12 2009-05-01 The Kitasato Institute Sustancia antihelmintica fki-1033 y procedimiento para la produccion de la misma.
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
ES2380408T3 (es) 2008-08-28 2012-05-11 Pfizer Inc. Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
RS62130B1 (sr) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
EP3397638B1 (en) 2015-12-28 2023-08-23 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
MX2022001764A (es) 2019-08-14 2022-08-04 Vetoquinol Sa Composiciones que comprenden tigolaner para el control de parasitos.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
DK0634408T3 (da) * 1992-03-17 2002-04-22 Fujisawa Pharmaceutical Co Depsipeptidderivater, fremstilling og anvendelse deraf
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (en) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha High-concentration aureobasidin preparation in solution form
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
ATE295167T1 (de) * 1998-03-19 2005-05-15 Merck & Co Inc Schwefelpentafluorophenylpyrazole zur kontrolle von ektoparasitenbefall
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
PL357551A1 (en) 2004-07-26
WO2001062268A1 (de) 2001-08-30
NO20023976L (no) 2002-10-21
NZ520856A (en) 2005-04-29
ATE343394T1 (de) 2006-11-15
ZA200205982B (en) 2003-07-28
DE10008128A1 (de) 2001-08-23
MXPA02008210A (es) 2003-01-28
JP2003523397A (ja) 2003-08-05
CN1309415C (zh) 2007-04-11
RU2002125493A (ru) 2004-03-20
PL203999B1 (pl) 2009-11-30
HK1054326A1 (en) 2003-11-28
ES2274871T3 (es) 2007-06-01
IL150988A (en) 2011-06-30
EP1259250B1 (de) 2006-10-25
AR028218A1 (es) 2003-04-30
BR0108562B1 (pt) 2013-03-05
NO328949B1 (no) 2010-06-28
CZ20022867A3 (cs) 2003-01-15
CZ300242B6 (cs) 2009-03-25
US20030125244A1 (en) 2003-07-03
HUP0204554A3 (en) 2005-05-30
AU4060501A (en) 2001-09-03
DK1259250T3 (da) 2007-02-26
RU2292905C2 (ru) 2007-02-10
KR20020072577A (ko) 2002-09-16
PT1259250E (pt) 2007-01-31
HK1054326B (zh) 2007-11-09
JP5596249B2 (ja) 2014-09-24
DE50111315D1 (de) 2006-12-07
NO20023976D0 (no) 2002-08-21
BR0108562A (pt) 2002-11-12
AR085989A2 (es) 2013-11-13
HUP0204554A2 (en) 2003-05-28
KR100755414B1 (ko) 2007-09-04
AU2001240605B2 (en) 2005-04-21
CA2400610A1 (en) 2001-08-30
EP1259250A1 (de) 2002-11-27
CA2400610C (en) 2013-01-22
CN1404397A (zh) 2003-03-19
JP2012107024A (ja) 2012-06-07

Similar Documents

Publication Publication Date Title
AU3391801A (en) Pyridinylimidazoles
DZ3293A1 (fr) Arylpyrazines substitues
AU8274301A (en) Electro-powder
AU6227101A (en) Substituted iminoazines
HUP0303043A3 (en) Rhinological agents
AU6803901A (en) Bis-arylsulfones
GB0015562D0 (en) Heterocycles
TWI315197B (en) Combinations
AU5825501A (en) Substituted benzoylcyclohexenones
AU6619001A (en) Liquid-pourers
PL358119A1 (en) Substituted phenyluracils
AU4060501A (en) Endoparasiticidal agents
AU2001240605A1 (en) Endoparasiticidal agents
AU7635401A (en) Hetaryl-substituted heterocycles
AU4686401A (en) Hypotensors
HUP0201201A3 (en) Endoparasiticidal agents
GB0028849D0 (en) Improved keysheath
AU2360402A (en) Substituted phenyluracils
AU4831301A (en) Gm-negative ehv-mutants
GB0004254D0 (en) Improved capodastro
GB2364426B (en) Improved capodastro
AU1852P (en) Tickit xTriticosecale
AU1702P (en) Trailblazer Xanthostemon chrysanthus
AU2117P (en) Gauka Gaura lindheimeri
GB0025070D0 (en) Contrast agents